Vaccination with antigenically complex hemagglutinin mixtures confers broad protection from influenza disease

Author:

Luo Zhaochen1ORCID,Miranda Hector A.1ORCID,Burke Kaitlyn N.1ORCID,Spurrier M. Ariel1ORCID,Berry Madison2,Stover Erica L.2,Spreng Rachel L.2ORCID,Waitt Greg3ORCID,Soderblom Erik J.3,Macintyre Andrew N.24ORCID,Wiehe Kevin24ORCID,Heaton Nicholas S.125ORCID

Affiliation:

1. Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.

2. Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.

3. Proteomics and Metabolomics Core Facility, Duke University School of Medicine, Durham, NC 27710, USA.

4. Duke Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.

5. Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710, USA.

Abstract

Current seasonal influenza virus vaccines induce responses primarily against immunodominant but highly plastic epitopes in the globular head of the hemagglutinin (HA) glycoprotein. Because of viral antigenic drift at these sites, vaccines need to be updated and readministered annually. To increase the breadth of influenza vaccine–mediated protection, we developed an antigenically complex mixture of recombinant HAs designed to redirect immune responses to more conserved domains of the protein. Vaccine-induced antibodies were disproportionally redistributed to the more conserved stalk of the HA without hindering, and in some cases improving, antibody responses against the head domain. These improved responses led to increased protection against homologous and heterologous viral challenges in both mice and ferrets compared with conventional vaccine approaches. Thus, antigenically complex protein mixtures can at least partially overcome HA head domain antigenic immunodominance and may represent a step toward a more universal influenza vaccine.

Publisher

American Association for the Advancement of Science (AAAS)

Reference60 articles.

1. World Health Organization Influenza (Seasonal) (World Health Organization 2023); https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).

2. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses;Hobson D.;J. Hyg.,1972

3. Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

4. Development of a Universal Influenza Vaccine

5. Is a Universal Influenza Virus Vaccine Possible?

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Human vaccines and immunotherapeutics: News May 2024;Human Vaccines & Immunotherapeutics;2024-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3